<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37510852</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>14</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>18</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Utility of Serum Ferritin for Predicting Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Patients with Long COVID.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4737</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm12144737</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The most common symptom of post-acute coronavirus disease 2019 (COVID-19) is fatigue, and it potentially leads to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS); however, a specific prognosticator is lacking. We aimed to elucidate the clinical characteristics of patients who developed ME/CFS after COVID-19.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this retrospective observational study, patients who visited Okayama University Hospital for long COVID between February 2021 and March 2022 were investigated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 234 patients, 139 (59.4%) had fatigue symptoms. Fifty patients with fatigue symptoms (21.4%) met the criteria for ME/CFS (ME/CFS group), while the other 89 patients did not (non-ME/CFS group); 95 patients had no fatigue complaints (no-fatigue group). Although the patients' backgrounds were not significantly different between the three groups, the ME/CFS group presented the highest scores on the self-rating symptom scales, including the Fatigue Assessment Scale (FAS), EuroQol, and the Self-Rating Depression Scale (SDS). Furthermore, serum ferritin levels, which were correlated with FAS and SDS scores, were significantly higher in the ME/CFS group (193.0 &#x3bc;g/L, interquartile range (IQR): 58.8-353.8) than in the non-ME/CFS group (98.2 &#x3bc;g/L, 40.4-251.5) and no-fatigue group (86.7 &#x3bc;g/L, 37.5-209.0), and a high serum ferritin level was prominent in female patients. Endocrine workup further showed that the ME/CFS group had higher thyrotropin levels but lower growth hormone levels in serum and that insulin-like growth factor-I levels were inversely correlated with ferritin levels (R = -0.328, <i>p</i> &lt; 0.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Serum ferritin level is a possible predictor of the development of ME/CFS related to long COVID, especially in female patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Yukichika</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-5545-3336</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otsuka</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-6015-6128</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tokumasu</LastName><ForeName>Kazuki</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-9513-6864</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sunada</LastName><ForeName>Naruhiko</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakano</LastName><ForeName>Yasuhiro</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-9972-791X</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Honda</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-6098-5006</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakurada</LastName><ForeName>Yasue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasegawa</LastName><ForeName>Toru</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hagiya</LastName><ForeName>Hideharu</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-5086-1891</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otsuka</LastName><ForeName>Fumio</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-7014-9095</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>JP22K20927</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">ferritin</Keyword><Keyword MajorTopicYN="N">insulin-like growth factor-I (IGF-I)</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>11</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>11</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>1</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37510852</ArticleId><ArticleId IdType="pmc">PMC10381392</ArticleId><ArticleId IdType="doi">10.3390/jcm12144737</ArticleId><ArticleId IdType="pii">jcm12144737</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lam I.C.H., Wong C.K.H., Zhang R., Chui C.S.L., Lai F.T.T., Li X., Chan E.W.Y., Luo H., Zhang Q., Man K.K.C., et al. Long-term post-acute sequelae of COVID-19 infection: A retrospective, multi-database cohort study in Hong Kong and the UK. EClinicalMedicine. 2023;60:102000. doi: 10.1016/j.eclinm.2023.102000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.102000</ArticleId><ArticleId IdType="pmc">PMC10173760</ArticleId><ArticleId IdType="pubmed">37197226</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V., Jayadevan R., Sashidharan S. Long COVID: An overview. Diabetes Metab. Syndr. 2021;15:869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Otsuka Y., Tokumasu K., Nakano Y., Honda H., Sakurada Y., Sunada N., Omura D., Hasegawa K., Hagiya H., Obika M., et al. Clinical characteristics of Japanese patients who visited a COVID-19 aftercare clinic for post-acute sequelae of COVID-19/long COVID. Cureus. 2021;13:e18568. doi: 10.7759/cureus.18568.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.18568</ArticleId><ArticleId IdType="pmc">PMC8571943</ArticleId><ArticleId IdType="pubmed">34760415</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T., Hittle M., Goodman S.N. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: A systematic review. JAMA Netw. Open. 2021;4:e2111417. doi: 10.1001/jamanetworkopen.2021.11417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandler C.X., Wyller V.B.B., Moss-Morris R., Buchwald D., Crawley E., Hautvast J., Katz B.Z., Knoop H., Little P., Taylor R., et al. Long COVID and post-infective fatigue syndrome: A review. Open Forum Infect. Dis. 2021;8:ofab440. doi: 10.1093/ofid/ofab440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab440</ArticleId><ArticleId IdType="pmc">PMC8496765</ArticleId><ArticleId IdType="pubmed">34631916</ArticleId></ArticleIdList></Reference><Reference><Citation>Soejima Y., Otsuka Y., Tokumasu K., Nakano Y., Harada K., Nakamoto K., Sunada N., Sakurada Y., Hasegawa K., Hagiya H., et al. Late-onset hypogonadism in a male patient with long COVID diagnosed by exclusion of ME/CFS. Medicina. 2022;58:536. doi: 10.3390/medicina58040536.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58040536</ArticleId><ArticleId IdType="pmc">PMC9025899</ArticleId><ArticleId IdType="pubmed">35454374</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunada N., Honda H., Nakano Y., Yamamoto K., Tokumasu K., Sakurada Y., Matsuda Y., Hasegawa T., Otsuka Y., Obika M., et al. Hormonal trends in patients suffering from long COVID symptoms. Endocr. J. 2022;69:1173&#x2013;1181. doi: 10.1507/endocrj.EJ22-0093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.EJ22-0093</ArticleId><ArticleId IdType="pubmed">35491089</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokumasu K., Honda H., Sunada N., Sakurada Y., Matsuda Y., Yamamoto K., Nakano Y., Hasegawa T., Yamamoto Y., Otsuka Y., et al. Clinical characteristics of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) diagnosed in patients with long COVID. Medicina. 2022;58:850. doi: 10.3390/medicina58070850.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58070850</ArticleId><ArticleId IdType="pmc">PMC9325226</ArticleId><ArticleId IdType="pubmed">35888568</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto Y., Otsuka Y., Sunada N., Tokumasu K., Nakano Y., Honda H., Sakurada Y., Hagiya H., Hanayama Y., Otsuka F. Detection of male hypogonadism in patients with post COVID-19 condition. J. Clin. Med. 2022;11:1955. doi: 10.3390/jcm11071955.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11071955</ArticleId><ArticleId IdType="pmc">PMC8999458</ArticleId><ArticleId IdType="pubmed">35407562</ArticleId></ArticleIdList></Reference><Reference><Citation>Boaventura P., Macedo S., Ribeiro F., Jaconiano S., Soares P. Post-COVID-19 condition: Where are we now? Life. 2022;12:517. doi: 10.3390/life12040517.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12040517</ArticleId><ArticleId IdType="pmc">PMC9029703</ArticleId><ArticleId IdType="pubmed">35455008</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim E.J., Son C.G. Review of case definitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) J. Transl. Med. 2020;18:289. doi: 10.1186/s12967-020-02455-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02455-0</ArticleId><ArticleId IdType="pmc">PMC7391812</ArticleId><ArticleId IdType="pubmed">32727489</ArticleId></ArticleIdList></Reference><Reference><Citation>Deumer U.S., Varesi A., Floris V., Savioli G., Mantovani E., Lopez-Carrasco P., Rosati G.M., Prasad S., Ricevuti G. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): An overview. J. Clin. Med. 2021;10:4786. doi: 10.3390/jcm10204786.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10204786</ArticleId><ArticleId IdType="pmc">PMC8538807</ArticleId><ArticleId IdType="pubmed">34682909</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotzny F., Blanco J., Capelli E., Castro-Marrero J., Steiner S., Murovska M., Scheibenbogen C., European Network on ME/CFS Myalgic encephalomyelitis/chronic fatigue syndrome&#x2014;Evidence for an autoimmune disease. Autoimmun. Rev. 2018;17:601&#x2013;609. doi: 10.1016/j.autrev.2018.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2018.01.009</ArticleId><ArticleId IdType="pubmed">29635081</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim E.J., Ahn Y.C., Jang E.S., Lee S.W., Lee S.H., Son C.G. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) J. Transl. Med. 2020;18:100. doi: 10.1186/s12967-020-02269-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02269-0</ArticleId><ArticleId IdType="pmc">PMC7038594</ArticleId><ArticleId IdType="pubmed">32093722</ArticleId></ArticleIdList></Reference><Reference><Citation>Dibble J.J., McGrath S.J., Ponting C.P. Genetic risk factors of ME/CFS: A critical review. Hum. Mol. Genet. 2020;29:R117&#x2013;R124. doi: 10.1093/hmg/ddaa169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddaa169</ArticleId><ArticleId IdType="pmc">PMC7530519</ArticleId><ArticleId IdType="pubmed">32744306</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., Komaroff A. The chronic fatigue syndrome: A comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann. Intern. Med. 1994;121:953&#x2013;959. doi: 10.7326/0003-4819-121-12-199412150-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType="pubmed">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers B.M., Jain A.K., De Meirleir K.L., Peterson D.L., Klimas N.G., Lerner A.M., Bested A.C., Flor-Henry P., Joshi P., Powles A.P. Myalgic encephalomyelitis/chronic fatigue syndrome: Clinical working case definition, diagnostic and treatment protocols. J. Chronic Fatigue Syndr. 2003;11:7&#x2013;115. doi: 10.1300/J092v11n01_02.</Citation><ArticleIdList><ArticleId IdType="doi">10.1300/J092v11n01_02</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton E.W. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: An IOM report on redefining an illness. JAMA. 2015;313:1101&#x2013;1102. doi: 10.1001/jama.2015.1346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.1346</ArticleId><ArticleId IdType="pubmed">25668027</ArticleId></ArticleIdList></Reference><Reference><Citation>de Kleijn W.P., De Vries J., Wijnen P.A., Drent M. Minimal (clinically) important differences for the Fatigue Assessment Scale in sarcoidosis. Respir. Med. 2011;105:1388&#x2013;1395. doi: 10.1016/j.rmed.2011.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2011.05.004</ArticleId><ArticleId IdType="pubmed">21700440</ArticleId></ArticleIdList></Reference><Reference><Citation>Drent M., Lower E.E., De Vries J. Sarcoidosis-associated fatigue. Eur. Respir. J. 2012;40:255&#x2013;263. doi: 10.1183/09031936.00002512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00002512</ArticleId><ArticleId IdType="pubmed">22441750</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabin R., de Charro F. EQ-5D: A measure of health status from the EuroQol Group. Ann. Med. 2001;33:337&#x2013;343. doi: 10.3109/07853890109002087.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/07853890109002087</ArticleId><ArticleId IdType="pubmed">11491192</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawada T., Suzuki S., Kubota F., Ohnishi N., Satoh K. Content and cross validity of the Todai Health Index depression scale in relation to the Center for Epidemiologic Studies Depression Scale and the Zung Self-rating Depression Scale. J. Occup. Health. 1999;41:154&#x2013;159. doi: 10.1539/joh.41.154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1539/joh.41.154</ArticleId></ArticleIdList></Reference><Reference><Citation>Zung W.W., Richards C.B., Short M.J. Self-rating depression scale in an outpatient clinic. Further validation of the SDS. Arch. Gen. Psychiatry. 1965;13:508&#x2013;515. doi: 10.1001/archpsyc.1965.01730060026004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpsyc.1965.01730060026004</ArticleId><ArticleId IdType="pubmed">4378854</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusano M., Shimoyama Y., Sugimoto S., Kawamura O., Maeda M., Minashi K., Kuribayashi S., Higuchi T., Zai H., Ino K., et al. Development and evaluation of FSSG: Frequency scale for the symptoms of GERD. J. Gastroenterol. 2004;39:888&#x2013;891. doi: 10.1007/s00535-004-1417-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00535-004-1417-7</ArticleId><ArticleId IdType="pubmed">15565409</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanda Y. Investigation of the freely available easy-to-use software &#x2018;EZR&#x2019; for medical statistics. Bone Marrow Transpl. 2013;48:452&#x2013;458. doi: 10.1038/bmt.2012.244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bmt.2012.244</ArticleId><ArticleId IdType="pmc">PMC3590441</ArticleId><ArticleId IdType="pubmed">23208313</ArticleId></ArticleIdList></Reference><Reference><Citation>Kernan K.F., Carcillo J.A. Hyperferritinemia and inflammation. Int. Immunol. 2017;29:401&#x2013;409. doi: 10.1093/intimm/dxx031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxx031</ArticleId><ArticleId IdType="pmc">PMC5890889</ArticleId><ArticleId IdType="pubmed">28541437</ArticleId></ArticleIdList></Reference><Reference><Citation>Senjo H., Higuchi T., Okada S., Takahashi O. Hyperferritinemia: Causes and significance in a general hospital. Hematology. 2018;23:817&#x2013;822. doi: 10.1080/10245332.2018.1488569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10245332.2018.1488569</ArticleId><ArticleId IdType="pubmed">29914346</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Knovich M.A., Coffman L.G., Torti F.M., Torti S.V. Serum ferritin: Past, present and future. Biochim. Biophys. Acta. 2010;1800:760&#x2013;769. doi: 10.1016/j.bbagen.2010.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2010.03.011</ArticleId><ArticleId IdType="pmc">PMC2893236</ArticleId><ArticleId IdType="pubmed">20304033</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes Rivera M., Mastronardi C., Silva-Aldana C.T., Arcos-Burgos M., Lidbury B.A. Myalgic encephalomyelitis/chronic fatigue syndrome: A comprehensive review. Diagnostics. 2019;9:91. doi: 10.3390/diagnostics9030091.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics9030091</ArticleId><ArticleId IdType="pmc">PMC6787585</ArticleId><ArticleId IdType="pubmed">31394725</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G., Anderson G., Maes M. Hypothalamic-pituitary-adrenal hypofunction in myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) as a consequence of activated immune-inflammatory and oxidative and nitrosative pathways. Mol. Neurobiol. 2017;54:6806&#x2013;6819. doi: 10.1007/s12035-016-0170-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-0170-2</ArticleId><ArticleId IdType="pubmed">27766535</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa S., Nora-Krukle Z., Henning N., Eliassen E., Shikova E., Harrer T., Scheibenbogen C., Murovska M., Prusty B.K., European Network on ME/CFS Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) J. Transl. Med. 2018;16:268. doi: 10.1186/s12967-018-1644-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1644-y</ArticleId><ArticleId IdType="pmc">PMC6167797</ArticleId><ArticleId IdType="pubmed">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal R., Gubbi S., Koch C.A. COVID-19 and chronic fatigue syndrome: An endocrine perspective. J. Clin. Transl. Endocrinol. 2022;27:100284. doi: 10.1016/j.jcte.2021.100284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcte.2021.100284</ArticleId><ArticleId IdType="pmc">PMC8641402</ArticleId><ArticleId IdType="pubmed">34877261</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai A.D., Lavelle M., Boursiquot B.C., Wan E.Y. Long-term complications of COVID-19. Am. J. Physiol. Cell Physiol. 2022;322:C1&#x2013;C11. doi: 10.1152/ajpcell.00375.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00375.2021</ArticleId><ArticleId IdType="pmc">PMC8721906</ArticleId><ArticleId IdType="pubmed">34817268</ArticleId></ArticleIdList></Reference><Reference><Citation>Tana C., Bentivegna E., Cho S.J., Harriott A.M., Garc&#xed;a-Azor&#xed;n D., Labastida-Ramirez A., Ornello R., Raffaelli B., Beltr&#xe1;n E.R., Ruscheweyh R., et al. Long COVID headache. J. Headache Pain. 2022;23:93. doi: 10.1186/s10194-022-01450-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-022-01450-8</ArticleId><ArticleId IdType="pmc">PMC9340759</ArticleId><ArticleId IdType="pubmed">35915417</ArticleId></ArticleIdList></Reference><Reference><Citation>Tana C., Giamberardino M.A., Martelletti P. Long COVID and especially headache syndromes. Curr. Opin. Neurol. 2023;36:168&#x2013;174. doi: 10.1097/WCO.0000000000001153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000001153</ArticleId><ArticleId IdType="pubmed">37078648</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda S., Nojima J., Motoki Y., Yamaguti K., Nakatomi Y., Okawa N., Fujiwara K., Watanabe Y., Kuratsune H. A potential biomarker for fatigue: Oxidative stress and anti-oxidative activity. Biol. Psychol. 2016;118:88&#x2013;93. doi: 10.1016/j.biopsycho.2016.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsycho.2016.05.005</ArticleId><ArticleId IdType="pubmed">27224647</ArticleId></ArticleIdList></Reference><Reference><Citation>Loebel M., Grabowski P., Heidecke H., Bauer S., Hanitsch L.G., Wittke K., Meisel C., Reinke P., Volk H.D., Fluge O., et al. Antibodies to beta adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome. Brain Behav. Immun. 2016;52:32&#x2013;39. doi: 10.1016/j.bbi.2015.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2015.09.013</ArticleId><ArticleId IdType="pubmed">26399744</ArticleId></ArticleIdList></Reference><Reference><Citation>Baklund I.H., Dammen T., Moum T.A., Kristiansen W., Duarte D.S., Castro-Marrero J., Helland I.B., Strand E.B. Evaluating routine blood tests according to clinical symptoms and diagnostic criteria in individuals with myalgic encephalomyelitis/chronic fatigue syndrome. J. Clin. Med. 2021;10:3105. doi: 10.3390/jcm10143105.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10143105</ArticleId><ArticleId IdType="pmc">PMC8307418</ArticleId><ArticleId IdType="pubmed">34300271</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman L., Bested A.C., Bonilla H.F., Chheda B.V., Chu L., Curtin J.M., Dempsey T.T., Dimmock M.E., Dowell T.G., Felsenstein D., et al. Myalgic encephalomyelitis/chronic fatigue syndrome: Essentials of diagnosis and management. Mayo Clin. Proc. 2021;96:2861&#x2013;2878. doi: 10.1016/j.mayocp.2021.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.07.004</ArticleId><ArticleId IdType="pubmed">34454716</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacul L., Authier F.J., Scheibenbogen C., Lorusso L., Helland I.B., Martin J.A., Sirbu C.A., Mengshoel A.M., Polo O., Behrends U., et al. European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert consensus on the diagnosis, service provision, and care of people with ME/CFS in Europe. Medicina. 2021;57:510. doi: 10.3390/medicina57050510.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050510</ArticleId><ArticleId IdType="pmc">PMC8161074</ArticleId><ArticleId IdType="pubmed">34069603</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahroum N., Alghory A., Kiyak Z., Alwani A., Seida R., Alrais M., Shoenfeld Y. Ferritin&#x2014;From iron, through inflammation and autoimmunity, to COVID-19. J. Autoimmun. 2022;126:102778. doi: 10.1016/j.jaut.2021.102778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2021.102778</ArticleId><ArticleId IdType="pmc">PMC8647584</ArticleId><ArticleId IdType="pubmed">34883281</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng L., Li H., Li L., Liu C., Yan S., Chen H., Li Y. Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. J. Clin. Lab. Anal. 2020;34:e23618. doi: 10.1002/jcla.23618.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.23618</ArticleId><ArticleId IdType="pmc">PMC7595919</ArticleId><ArticleId IdType="pubmed">33078400</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaushal K., Kaur H., Sarma P., Bhattacharyya A., Sharma D.J., Prajapat M., Pathak M., Kothari A., Kumar S., Rana S., et al. Serum ferritin as a predictive biomarker in COVID-19. a systematic review, meta-analysis and meta-regression analysis. J. Crit. Care. 2022;67:172&#x2013;181. doi: 10.1016/j.jcrc.2021.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2021.09.023</ArticleId><ArticleId IdType="pmc">PMC8604557</ArticleId><ArticleId IdType="pubmed">34808527</ArticleId></ArticleIdList></Reference><Reference><Citation>Clemente I., Sinatti G., Cirella A., Santini S.J., Balsano C. Alteration of inflammatory parameters and psychological post-traumatic syndrome in long-COVID patients. Int. J. Environ. Res. Public Health. 2022;19:7103. doi: 10.3390/ijerph19127103.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19127103</ArticleId><ArticleId IdType="pmc">PMC9222533</ArticleId><ArticleId IdType="pubmed">35742355</ArticleId></ArticleIdList></Reference><Reference><Citation>Elanwar R., Hussein M., Magdy R., Eid R.A., Yassien A., Abdelsattar A.S., Alsharaway L.A., Fathy W., Hassan A., Kamal Y.S. Physical and mental fatigue in subjects recovered from COVID-19 infection: A case-control study. Neuropsychiatr. Dis. Treat. 2021;17:2063&#x2013;2071. doi: 10.2147/NDT.S317027.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NDT.S317027</ArticleId><ArticleId IdType="pmc">PMC8235935</ArticleId><ArticleId IdType="pubmed">34188476</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasini E., Corsetti G., Romano C., Scarabelli T.M., Chen-Scarabelli C., Saravolatz L., Dioguardi F.S. Serum metabolic profile in patients with long-covid (PASC) syndrome: Clinical implications. Front. Med. 2021;8:714426. doi: 10.3389/fmed.2021.714426.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.714426</ArticleId><ArticleId IdType="pmc">PMC8339407</ArticleId><ArticleId IdType="pubmed">34368201</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T., Grubwieser P., Sahanic S., B&#xf6;hm A.K., Pizzini A., Luger A., Schwabl C., Koppelst&#xe4;tter S., Kurz K., Puchner B., et al. The Impact of Iron Dyshomeostasis and Anaemia on Long-Term Pulmonary Recovery and Persisting Symptom Burden after COVID-19: A Prospective Observational Cohort Study. Metabolites. 2022;12:546. doi: 10.3390/metabo12060546.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12060546</ArticleId><ArticleId IdType="pmc">PMC9228477</ArticleId><ArticleId IdType="pubmed">35736479</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehsani S. COVID-19 and iron dysregulation: Distant sequence similarity between hepcidin and the novel coronavirus spike glycoprotein. Biol. Direct. 2020;15:19. doi: 10.1186/s13062-020-00275-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13062-020-00275-2</ArticleId><ArticleId IdType="pmc">PMC7563913</ArticleId><ArticleId IdType="pubmed">33066821</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C., Freitag H., Meyer-Arndt L., Wittke K., Hanitsch L.G., Zoller T., Steinbeis F., Haffke M., Rudolf G., Heidecker B., et al. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat. Commun. 2022;13:5104. doi: 10.1038/s41467-022-32507-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32507-6</ArticleId><ArticleId IdType="pmc">PMC9426365</ArticleId><ArticleId IdType="pubmed">36042189</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Nunez B., Tarasse R., Vogelaar E.F., Janneke Dijck-Brouwer D.A., Muskiet F.A.J. Higher prevalence of &#x201c;Low T3 Syndrome&#x201d; in patients with chronic fatigue syndrome: A case-control study. Front. Endocrinol. 2018;9:97. doi: 10.3389/fendo.2018.00097.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2018.00097</ArticleId><ArticleId IdType="pmc">PMC5869352</ArticleId><ArticleId IdType="pubmed">29615976</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackerman D., Gems D. Insulin/IGF-1 and hypoxia signaling act in concert to regulate iron homeostasis in Caenorhabditis elegans. PLoS Genet. 2012;8:e1002498. doi: 10.1371/journal.pgen.1002498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1002498</ArticleId><ArticleId IdType="pmc">PMC3291539</ArticleId><ArticleId IdType="pubmed">22396654</ArticleId></ArticleIdList></Reference><Reference><Citation>Torti F.M., Torti S.V. Regulation of ferritin genes and protein. Blood. 2002;99:3505&#x2013;3516. doi: 10.1182/blood.V99.10.3505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V99.10.3505</ArticleId><ArticleId IdType="pubmed">11986201</ArticleId></ArticleIdList></Reference><Reference><Citation>Estivariz C.F., Ziegler T.R. Nutrition and the insulin-like growth factor system. Endocrine. 1997;7:65&#x2013;71. doi: 10.1007/BF02778066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02778066</ArticleId><ArticleId IdType="pubmed">9449035</ArticleId></ArticleIdList></Reference><Reference><Citation>Maggio M., De Vita F., Lauretani F., Butto V., Bondi G., Cattabiani C., Nouvenne A., Meschi T., Dall&#x2019;Aglio E., Ceda G.P. IGF-1, the cross road of the nutritional, inflammatory and hormonal pathways to frailty. Nutrients. 2013;5:4184&#x2013;4205. doi: 10.3390/nu5104184.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu5104184</ArticleId><ArticleId IdType="pmc">PMC3820068</ArticleId><ArticleId IdType="pubmed">24152751</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>